![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 12
Zeitschriftenartikel
Braciak, Todd A.; Roskopf, Claudia C.; Wildenhain, Sarah; Fenn, Nadja C.; Schiller, Christian B.; Schubert, Ingo A.; Jacob, Uwe; Honegger, Annemarie; Krupka, Christina; Subklewe, Marion; Spiekermann, Karsten; Hopfner, Karl-Peter; Fey, Georg H.; Aigner, Michael; Krause, Stefan; Mackensen, Andreas und Oduncu, Fuat S.
(2018):
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cells.
In: Oncoimmunology, Bd. 7, Nr. 9, e1472195
Li, Pan; Ou, Qingjian; Braciak, Todd A.; Chen, Gong und Oduncu, Fuat S.
(2018):
MicroRNA-192-5p is a predictive biomarker of survival for Stage IIIB colon cancer patients.
In: Japanese Journal of Clinical Oncology, Bd. 48, Nr. 7: S. 619-624
Li, Pan; Xiao, Zhi-Tao; Braciak, Todd A.; Ou, Qing-Jian; Chen, Gong und Oduncu, Fuat S.
(2017):
Evidence for an Association of ERCC1 Expression and Mismatch Repair Status with Overall Survival in Colorectal Cancer Patients.
In: Oncology Research and Treatment, Bd. 40, Nr. 11: S. 702-706
Li, Pan; Xiao, Zhitao; Braciak, Todd A.; Ou, Qingjian; Chen, Gong und Oduncu, Fuat S.
(2017):
Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
In: PLOS One 12(8), e0181615 [PDF, 3MB]
In: PLOS One 12(8), e0181615 [PDF, 3MB]
Li, Pan; Xiao, Zhi-Tao; Braciak, Todd A.; Ou, Qing-Jian; Chen, Gong und Oduncu, Fuat S.
(2017):
Impact of age and mismatch repair status on survival in colorectal cancer.
In: Cancer Medicine, Bd. 6, Nr. 5: S. 975-981
[PDF, 368kB]
Li, Pan; Xiao, Zhitao; Braciak, Todd A.; Ou, Qingjian; Chen, Gong und Oduncu, Fuat S.
(2017):
A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
In: PLOS One 12(3), e0172799 [PDF, 981kB]
In: PLOS One 12(3), e0172799 [PDF, 981kB]
Roskopf, Claudia C.; Braciak, Todd A.; Fenn, Nadja C.; Kobold, Sebastian; Fey, Georg H.; Hopfner, Karl-Peter und Oduncu, Fuat S.
(2016):
Dual-targeting triplebody 33-3-19 mediates selective lysis of biphenotypic CD19(+) CD33(+) leukemia cells.
In: Oncotarget, Bd. 7, Nr. 16: S. 22579-22589
Li, Pan; Xiao, Zhi-Tao; Braciak, Todd A.; Ou, Qing-Jan; Chen, Gong und Oduncu, Fuat S.
(2016):
Association between Ki67 Index and Clinicopathological Features in Colorectal Cancer.
In: Oncology Research and Treatment, Bd. 39, Nr. 11: S. 696-702
[PDF, 407kB]
Chatzopoulou, Elisavet I.; Sekhavati, Farzad; Braciak, Todd A.; Fey, Georg H. und Rädler, Joachim O.
(2016):
Time-Resolved Study of Triplebody-Mediated Lysis by Natural Killer Cells on Microstructured Target Cell Arrays.
In: Biophysical Journal, Bd. 110, Nr. 3:
487A-487A
Chatzopoulou, Elisavet I.; Roskopf, Claudia C.; Sekhavati, Farzad; Braciak, Todd A.; Fenn, Nadja C.; Hopfner, Karl-Peter; Oduncu, Fuat S.; Fey, Georg H. und Rädler, Joachim O.
(2016):
Chip-based platform for dynamic analysis of NK cell cytolysis mediated by a triplebody.
In: Analyst, Bd. 141, Nr. 7: S. 2284-2295
Schiller, Christian B.; Braciak, Todd A.; Fenn, Nadja C.; Seidel, Ursula J. E.; Roskopf, Claudia C.; Wildenhain, Sarah; Honegger, Annemarie; Schubert, Ingo A.; Schele, Alexandra; Lämmermann, Kerstin; Fey, Georg H.; Jacob, Uwe; Lang, Peter; Hopfner, Karl-Peter und Oduncu, Fuat S.
(2016):
CD19-specific triplebody SPM-1 engages NK and gd T cells for rapid and efficient lysis of malignant B-lymphoid cells.
In: Oncotarget, Bd. 7, Nr. 50: S. 83392-83408
Braciak, Todd A.; Wildenhain, Sarah; Roskopf, Claudia C.; Schubert, Ingo A.; Fey, Georg H.; Jacob, Uwe; Hopfner, Karl-Peter und Oduncu, Fuat S.
(2013):
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2.
In: Journal of Translational Medicine
11:289
[PDF, 3MB]